Leflunomide in the treatment of rheumatoid arthritis. An analysis of predictors for treatment continuation
about
Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritisReappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis.Efficacy at 52 weeks of daily clinical use of iguratimod in patients with rheumatoid arthritis.
P2860
Leflunomide in the treatment of rheumatoid arthritis. An analysis of predictors for treatment continuation
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Leflunomide in the treatment o ...... ors for treatment continuation
@ast
Leflunomide in the treatment o ...... ors for treatment continuation
@en
type
label
Leflunomide in the treatment o ...... ors for treatment continuation
@ast
Leflunomide in the treatment o ...... ors for treatment continuation
@en
prefLabel
Leflunomide in the treatment o ...... ors for treatment continuation
@ast
Leflunomide in the treatment o ...... ors for treatment continuation
@en
P2093
P2860
P1476
Leflunomide in the treatment o ...... ors for treatment continuation
@en
P2093
E N van Roon
H J Bernelot Moens
J R B J Brouwers
M A F J van de Laar
M Hoekstra
T L Th A Jansen
P2860
P304
P356
10.1111/J.1365-2125.2005.02430.X
P407
P577
2005-09-01T00:00:00Z